Genix Pharmaceuticals appoints Raylen Tamayo as new CFO, replacing Danny Lee.

Genix Pharmaceuticals announced the resignation of CFO Danny Lee, effective April 30, 2026, as he shifts focus to other business commitments. The company appointed Raylen Tamayo as the new CFO starting May 4, 2026. Tamayo brings over eight years of finance experience, including expertise in IFRS compliance, financial reporting, and IPO advisory. This leadership change aims to support Genix's ongoing development and commercialization of innovative ophthalmic products.